# Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis

> **NCT02158988** · PHASE3 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 105 (actual)

## Conditions studied

- Malignant Neoplasm of Stomach
- Secondary Malignant Neoplasm of Peritoneum
- Secondary Malignant Neoplasm of Other and Unspecified Sites

## Interventions

- **PROCEDURE:** HIPEC

## Key facts

- **NCT ID:** NCT02158988
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-01
- **Primary completion:** 2020-10-01
- **Final completion:** 2021-06-09
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2021-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02158988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02158988, "Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02158988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*